Skip to main content
Iranian Journal of Basic Medical Sciences logoLink to Iranian Journal of Basic Medical Sciences
. 2018 Dec;21(12):1210–1220. doi: 10.22038/IJBMS.2018.30520.7355

The roles of RFamide-related peptides (RFRPs), mammalian gonadotropin-inhibitory hormone (GnIH) orthologues in female reproduction

Huimei Wang 1, Arezoo Khoradmehr 2, Mohammad Jalali 3, Mohammad Saied Salehi 4, Kazuyoshi Tsutsui 5, Mohammad Reza Jafarzadeh Shirazi 6, Amin Tamadon 3,*
PMCID: PMC6312679  PMID: 30627363

Abstract

Objective(s):

To benefit from reproduction and deal with challenges in the environmental conditions, animals must adapt internal physiology to maximize the reproduction rate. Maladaptive variations in the neurochemical systems and reproductive system can lead to manifestation of several significant mammalian reprocesses, including mammalian ovarian lifespan. RFamide-related peptide (RFRP, Rfrp), mammalian orthologues of gonadotropin-inhibitory hormone (GnIH), which is a regulator to prevent the gonadotropin-releasing hormone (GnRH) neural activity, is known to be related to reproductive traits. This review aimed to summarize recent five-year observations to outline historic insights and novel perspectives into the functions of RFRPs in coding the mammalian reproductive physiology, especially highlight recent advances in the impact on RFRPs in regulating mammalian ovary lifespan.

Materials and Methods:

We reviewed the recent five-year important findings of RFRP system involved in mammalian ovary development. Data for this review were collected from Google Scholar and PubMed using the RFRP keyword combined with the keywords related to physiological or pathological reproductive functions.

Results:

Recent discoveries are focused on three major fronts in research on RFRP role in female reproduction including reproductive functions, energy balance, and stress regulation. The roles of RFRPs in various development phases of mammal reproduction including prepuberty, puberty, estrous cycle, pregnancy, milking, menopause, and/or ovarian diseases have been shown.

Conclusion:

Overall, these recent advances demonstrate that RFRPs serve as critical mediators in mammalian ovarian development.

Key Words: Female, Gonadotropin-inhibitory- hormone, Mammals, RFamide-related peptide Reproduction

Introduction

For any species or individual to survive and thrive, there is a necessary biological need for the reproductive system to develop structures and mechanisms in order to ensure the greatest fertility. Physiological and psychological mechanisms facilitating the process of reproduction must be selected through evolution. The reproductive complexity has been reported on biological mechanisms of gonadotropin-releasing hormone (GnRH) isolated from both non-mammals and mammals and considered as the sole regulator of the hypothalamus-pituitary-gonad (HPG) axis for a long time. However, since the seminal discovery made by Tsutsui et al. (1), a gonadotropin-inhibitory hormone (GnIH) in the brain of quail producing inhibitory regulations on the reproductive axis, three essential questions have arisen: What brain sites are involved in the innervation of GnIH neurons? What role does GnIH play in ovarian development? What factors affect GnIH?

In the recent decades, enormous advances have accumulated in elucidating the physiological mechanisms of GnIH underlying reproductive processes in animals. Mammalian GnIH orthologues, RF (Arg-Phe) amide-related peptides (RFRPs), including RFRP-1 and RFRP-3, are considered as essential regulators of GnRH neurons (2) and HPG axis (3). Moreover, the field has also started to appreciate that various functionalities of RFRPs are affected by various factors, including social interactions (4), photoperiod (5), temperature (6), food (7), and some diseases (8) in ovarian developmental periods. Additionally, RFRPs play different roles in different genders (5) and species (9, 10) in the reproductive development (Figure 1). Furthermore, the discovery of RFRPs’ functionality from prepuberty to menopause created novel perspectives on how different ovarian developmental periods might be responsive to regulate reproduction through RFRPs.

Figure 1.

Figure 1

Relationships between different factors and RFamide-related peptides (RFRPs), mammalian gonadotropin-inhibitory hormone (GnIH) orthologues. Food, social interactions, photoperiod, and ovarian diseases are the common factors underlying the effects of RFRPs of mammalian ovarian development. For each of these mediators, different mammals and genders were studied. We suggest using various behavioral paradigms and intervention means to assess the influence of RFRPs on ovarian development periods, especially among mammals with different genetic backgrounds

In the recent five years, evidence began to mount that RFRPs have significant repressive influence on mammalian reproduction regulation in various species including rat (11, 12), mouse (13), desert jerboa (14), hamster (10, 15, 16), pig (17, 18), sheep (19), goat (20), cow (21), monkey (22), and human (23). Moreover, localization and projections of RFRP propeptides vary in different mammalian species (Table 1, Figure 2).

Table 1.

Innervation of RFamide-related peptide (RFRP) neurons in the hypothalamus in different mammalian species

Species Neuron localization Neuron projection Target neurons References
Human Dorsomedial region Preoptic area
Median eminence of pituitary
Luteinizing hormone (23)
Monkey Pituitary
All major types of testicular cells
Hypothalamus
Median eminence of pituitary
Gonadotropin-releasing hormone (22)
Pig Paraventricular nuclei
Dorsomedial nuclei
Lateral hypothalamic area Gonadotropin-releasing hormone
Leydig cells
(17, 18)
Cow Dorsomedial hypothalamus
Paraventricular nuclei
Median eminence of pituitary
Preoptic area
Gonadotropin-releasing hormone (21)
Sheep Anterior hypothalamus Mediobasal hypothalamus
Paraventricular nuclei
Dorsomedial hypothalamus
Median eminence of pituitary
Luteinizing hormone (19, 69)
Goat Hypothalamus Median eminence of pituitary Gonadotropin-releasing hormone (20)
Rat Dorsomedial hypothalamic nucleus
Arcuate nucleus
Lateral ventricle
Paraventricular nucleus
Dorsomedial nucleus
Arcuate nucleus
Kisspeptin
Neuropeptide Y
Gonadotropin releasing hormone
(11, 12)
Mouse Dorsomedial hypothalamic nucleus Arcuate nucleus
Anteroventral-periventricular hypothalamic nuclei
Kisspeptin
Gonadotropin releasing hormone
Proopiomelanocortin
Neuropeptide Y
(13)
Hamster Dorsomedial hypothalamic nucleus
Suprachiasmatic nucleus
Limbic brain regions
Septum
Striatum
Amygdala
Hypothalamus
Anteroventral–periventricular nucleus
Median eminence of pituitary
Median preoptic nucleus
Luteinizing hormone
Gonadotropin releasing hormone
Vasoactive intestinal peptide
Anteroventral periventricular nucleus
(5, 10, 15, 16, 61)
Jeroba Dorso/ventromedialVentro (VMH)-medial Hypothalamus Arcuate nucleus
Periventricular nucleus
Pro-opiomelanocortin
Neuropeptide Y
Somatostatin
Gonadotropin releasing hormone
(14)

Figure 2.

Figure 2

A simplified schematic summarizing the potential neural pathways of RFRP neurons in the hypothalamus in mammals. Abbreviations: DMH, Dorsomedial hypothalamic nucleus; POA, preoptic area; LS, lateral septum; PVT, paraventricular nucleus of the thalamus; PAG, periaqueductal gray; ARC, arcuate nucleus

In a compelling set of experiments on female hamsters, it has been demonstrated that the RFRP system exerts variable effects according to the season, the stage of the estrous cycle, and the time of the day, which are essential for synchronization of different reproductive activity (10). However, recent studies have also provided new insights that RFRP-3 may have no direct effect on controlling the secretion of luteinizing hormone (LH) in the ewe (9). Consistent with this hypothesis, RFRP-3 and GnRH immunoreactivities were unchanged in the bovine hypothalamus both in proestrus and diestrus (21). Therefore, we should not rule out the possibility that some functions mediated by the RFRP system may be different in a variety of species. The RFRP system robustly regulated by photoperiod in male and female Syrian hamsters showed more significant effects on females (5). However, further work is needed to classify the influence of RFRP in different genders and species.

Here, we review some important findings of the RFRP system involved in the development of mammalian ovary, emphasizing the recent five-year advances. Data for this review were collected from Google Scholar and PubMed using RF-amide-related peptides or RFRP combined with biochemistry, molecular physiology, ovary, prepuberty, puberty, estrous cycle, pregnancy, milking, menopause, and/or ovarian diseases as keywords. Supplemental literature searches used gonadotropin-releasing hormone, GnRH, gonadotropin-inhibitory hormone or GnIH combined with ovary, prepuberty, estrous cycle, pregnancy, milking, menopause, and ovarian diseases as keywords (Figure 3). A better understanding of the RFRP mechanisms underlying mammalian ovarian life-span may give novel insights into reproduction and therapies development for ovarian diseases.

Figure 3.

Figure 3

Efficacy of RFamide-related peptide (RFRP) signaling in regulating the reproduction of mammals. RFRP neurons generate an inhibitory activity in the hypothalamus-pituitary-gonad axis (HPG axis) via their G protein-coupled receptor. Abbreviations: GnRH, gonadotropin-releasing hormone; LH, luteinizing hormone; FSH, follicle-stimulating hormone

Biochemistry and molecular physiology of RFRP

The precursor of RFRPs is synthesized and processed into two mature neuropeptides, RFRP-3 and RFRP-1, characterized by a conserved C-terminal LPXRFamide (X = L or Q) motif (26). However, the structural differences between the two peptides exist in their C terminus by an LPLRFamide for RFRP-1 and LPQRFamide for RFRP-3, and N terminus is evidently different between two peptides among species (27). It has been implicated that RFRP-1 can stimulate prolactin secretion, although it does not have a similar effect on the other pituitary hormones including LH, follicle-stimulating hormone (FSH), adrenocorticotropin, growth hormone, and thyroid-stimulating hormone, suggesting that RFRP-1 may be involved in the regulatory functions of endocrine instead of coding reproduction. However, the impacts of RFRP-3 in mammals are even more elusive compared with RFRP-1 on regulating gonadotropins’ secretion (10, 13, 28-30). In addition, these studies were especially focused on the modulation of mammalian reproduction, including activating LH secretion and synthesis (10, 13) and modulating the process of puberty onset (28-30). In this regard, the exact mechanisms of RFRP-3 involved in mammalian ovarian development still require further confirmation.

RFRP in mammalian ovary life-span

Ovarian life-span considerably influences the reproductive process. Although apparent differences exist in the sequence and timing of ovarian development between mammalian species, ovaries of different mammals largely develop in a similar way. It is now clearly understood that the ovary, a multi-compartmental gonad in females, causes differentiation and release of the mature eggs or oocytes, produces steroids stimulating the development of female secondary sexual properties and supports functionalities of pregnancy. Moreover, the ovarian hormones also play an essential role in the processes from puberty development to ovulation and reproductive cycle (31). Animal and human studies have begun to recognize GnRH and RFRP are activated during mammalian reproduction. GnRH was once considered the single driver of gonadotropins and secretion of gonadotropins in the modulation of reproduction in mammals. Recently, extensive knowledge has accumulated on the investigation of reproductive mechanisms of RFRP, which is considered a potential inhibitory regulator of GnRH release in mammals. They indicated that the activity and expression of RFRP could modulate gonadotropin and GnRH secretion and are strongly linked to infertility and sexual behavior (32).

Extensive knowledge is accumulating on the neuroanatomical interactions that the gonadal GnIH system, independently from the brain, directly responds to changes in circulating glucocorticoids (46). In in vivo and in vitro conditions, RFRP-3 suppresses the secretion of gonadotropins in female sheep and rats (47, 48). Several studies also showed that RFRP-3 neurons project to GnRH neurons and inhibit LH secretion (49-51). Thus, RFRPs hinder the secretion and synthesis of gonadotropin via indirect and direct pituitary actions. In female sheep, it was proposed that RFRP-3 inhibited the pulse amplitude of LH and decreased gonadotropin secretion stimulated by GnRH (47). The possibility that the RFRP system plays an essential role in modulating the ovulation and LH surge in female hamsters has been suggested (52). Expanding on this, RFRP-3 inhibits the firing rate of GnRH in mice (53). RFRP-3 might exert its effects on reproduction either indirectly through upstream regulators of GnRH, and/or directly via a subset of GnRH neurons (41). RFRP decreased the expression of GnRH mRNA in a hypothalamic Rfrp-expressing cell model (54).

Together with recordings in avian species (55, 56), RFRP-3 is demonstrated to act as a regulator of HPG axis to support the general reproductive actions, suggesting that RPRPs may play a highly conserved local regulatory role in peripheral reproductive tissues and gonads. However, a large body of recordings suggests that the special local functions of RFRPs can differ across species (Table 2). Below, we discuss the roles of RFRPs in various development phases of mammals’ reproduction.

Table 2.

Studies confirmed the inhibitory role of the RFamide-related peptide (RFRP) on the hypothalamus-pituitary-gonad axis during ovarian life-span in different mammalian species

Species Ovarian lifespan References
Human Early puberty (27)
Menopause (23)
Monkey Prepuberty (22)
Pig Estrous cycle (54, 56, 65)
Cow Estrous cycle (21)
Sheep Estrous cycle (69)
Milking (19)
Goat Estrous cycle (20)
Rat Prepuberty (11)
Estrous cycle (57, 59, 92)
Pregnancy (83)
Milking (90)
Mouse Puberty (26, 39)
Estrous cycle (71)
Pregnancy (48)
Hamster Estrous cycle (5, 60, 61, 74)
Jeroba Estrous cycle (14)

Role of RFRP in puberty

Puberty onset modulated by reproductive neuroendocrine systems, is a complex and well-organized process. It is currently revealed that puberty is regulated via high-frequency hypothalamic GnRH pulsing. Furthermore, GnRH release secretes FSH and LH. Given the classical stimulatory role of GnRH in the regulation of the pituitary-gonadal axis, RFRP-3 is also involved in preventing reproduction as an inhibitory neuropeptide (57). As RFRP signaling exerts its impacts on the reproductive axis through gonadal and pituitary gonadotropins, finding the association of neural projections of RFRP from the hypothalamic nucleus with GnRH provided new possibilities of how RFRP systems may respond to prepubertal and pubertal periods.

Recent studies using common marmoset monkeys have proved a significant surge in the RFRP transcription level in the prepuberty of juvenile monkeys (22). In the early prepubertal period, a strong reduction was observed in the dorsomedial hypothalamic region (DMH) in RFRF-3/c-fos co-expression and RFRP-3 expression (29). This marked decrease in inhibiting RFRP-3 population might demonstrate that inhibition of GnRH neurons diminishes during early puberty in humans (29). Intracerebroventricular injection of RFRP-3 markedly delayed puberty onset of female rats, showing the possibility that RFRP-3 may be correlated with prepubertal increase in growth hormone secretion (11). Similarly, in female mice, the delayed pubertal onset could be due to the suppression of GnRH gene expression under dexamethasone treatment, accounting for the inhibitory signals from GnIH to the preoptic area to some degree (58). To explore the neuroendocrine mechanisms of RFRP-3 in social reproductive inhibition of puberty, it was found that exogenous RFRP-3 inhibits mating behavior and gonadal steroidogenesis in naked mole rats underlying the given inhibited circumstances of puberty (12). Importantly, the role of RFRP-3 in preserving immature reproduction provides proof that stimulatory peptides were not the sole regulators of puberty (59). Neonatal exposure to bisphenol A, which is well understood to lead to advances in puberty, persistent estrus, irregular estrous cycles, and compromised fertility, and can also induce premature puberty in female mammals (59-61). This is proved to result from decreased inhibition of GnRH neurons (59).

GPR47 as the RFRP cognate receptor is expressed in the testes, pituitary, and hypothalamus of mammals. Moreover, neuropeptide FF receptor 2 (NPFFR2), a putative receptor of RFRPs, was revealed to play a crucial role in pubertal onset in gilts (17). RFRP-3 might play a role in reproduction either indirectly by upstream modulators of GnRH or by GPR147 in a small proportion of murine GnRH neurons (41). Based on their prior work, a more careful examination of kisspeptin effects (the Kiss1 gene neuropeptide product) or RFRP-3 on modulating reproductive status revealed that RFRP-3 might affect a subset of neurons derived from kisspeptin in mice, especially in the arcuate nucleus (ARC) of mice. However, no evidence in this study proved that kisspeptin directly modulates reciprocal actions on RFRP-3 neurons (43). Likewise, in humans, RFRP-3/GPR147 may have secondary and modulatory effects on regulation of puberty (29).

RFRP-3 could suppress the release of pituitary LH effectively through inhibition of transcription and translation of GnRH in female mice, being connected with ovarian development periods and the estrogen signaling pathway (28). Moreover, central administration of RFRP-3 was shown to inhibit LH secretion in female mice when preovulatory LH surge in naive mouse or LH surge was generated through estradiol in ovariectomized mice (13). However, central administration of RFRP-3 had a low effect on LH secretion in both intact diestrus and low dose estradiol-administered ovariectomized mice (13). Low concentration of estradiol as an ovarian sex steroid might affect the mRNA expression of RFRP at the prepubertal stage (62). Expanding on this, sexual maturation progress was observed in rats treated with chronic testosterone, suggesting that this top-down control might be triggered by a peripheral, instead of a central mechanism (63). Additionally, peripheral RFRP-3 had no effect on intact female micee during diestrus or at preovulatory LH surge (13). This showed the effect of cycle stage-dependence on gonadotropin secretion in female mice. On the other hand, fluctuations of RFRP-3 in reaction to food restriction may modulate the HPG axis in prepubertal ewes (64).

An emerging theme is that endogenous RFRP-3 signaling might not play a necessary role in pubertal development, at least in some species suggesting novel hypotheses of how RFRP-3 may control sexual maturation and development (65). Most recently, an exciting novel wave of results has emerged, supporting that GnIH exerts its effects on proper pubertal development via regulating the hypothalamus-pituitary-thyroid (HPT) and HPG axes interactions (66).

Role of RFRP in the estrous cycle

The estrous cycle is the reproductive cycle found in most mammalian females whereby there are recurring periods starting from sexual maturity and ceasing at death, interrupted by anestrous stage or pregnancies and triggered by reproductive hormones. The RFRP gene of pigs has been cloned and characterized (33). Their work showed the close associations with RFRP gene and reproductive traits in pigs. A prominent view supported by data from immunolocalization in the pig ovary in the estrous cycle was that GnIH immunoreactivities and its receptor-GPR147 were localized mostly in the luteal cells in diestrus and metestrus and in the granulosa and theca cells of antral follicles during estrus and proestrus (67). To specifically clarify the potential locations and mechanisms of RFRP-3 action, the direct role of RFRP-3 in the reproductive axis of female pigs in vitro has been identified (34). They revealed that different doses of RFRP-3 inhibited the secretion and synthesis of gonadotropin, steroid hormones, and GnRH, and affected gene expression, including GnRH and Kiss1 and protein expressions such as ERK 1/2, cycling B1, and proliferating cell nuclear antigen. Similarly, RFRP neurons in the DMH are found to have a considerable impact on controlling estrous cyclicity in rats (36). In addition, GnRH and LH can be restrained to maintain pulsatile and low-amplitude release by estrogen negative feedback during the major phase of the ovulatory cycle (reviewed by Williams and Kriegsfeld (68). Based on these molecular and morphological results, the evidence suggests that RFRP may exert critical effects on the estrous cycle.

A current study showed that coordinated expression of RFRP-3 and Kiss1 mRNAs participated in response to estrous cycle in the hypothalamus in rats (37). The relationship between RFRP-3 and Kiss1 has been extensively explored in Syrian male hamsters (44), mice (41) and cows (21). These studies showed that decisive position of RFRP-3 can exert a stimulatory impact on the reproductive axis, most likely through hypothalamic targets. Although kisspeptin neurons do not have any direct reciprocal roles in RFRP-3 neurons, RFRP-3 acts as a stimulator to modulate a small proportion of neurons derived from kisspeptin in mice (43). Another study has shown that the roles of RFRP-3 are developmental status- and sex-dependent in hamsters (16).

Epidemiological and experimental findings reflected that circadian disruption plays pronounced negative roles in the female reproductive axis. Both GnRH and RFRP-3 neurons sustain their own circadian cycles to ensure inhibition and stimulation of the reproductive axis are coordinated precisely (25). Early recordings of the circadian system revealed interactions between estradiol-sensitive neural circuits, circadian timing, driving preovulatory LH surge, and GnRH secretion (68-70). A number of models in rodents suggest that RFRP-3 and kisspeptin neuronal populations play a key node for integrating and transducing hormonal and circadian signals to the reproductive axis, thus they control the LH surge, precisely and timely (5, 35, 71, 72). Some of these studies were dependent on circadian neural oscillations such as serotonergic and dopaminergic ones to study the age-dependent change in hypothalamic RFRP-3 expression and its relation with gonadal maturation and functions (57, 73, 74) (Sethi and Chaturvedi, 2015, 2016). They found that administration of L-DOPA and 5-HTP in breeder mice induced expression of RFRP-3 neurons in DMH nuclei and altered the testicular activity, simultaneously. In research exploring the photoperiodic regulation effect of goat RFRP gene during reproductive process, RFRP gene was proposed to be indirectly connected with reproductive seasonality and has undergone a selective pressure in sunshine duration in goats (20).

A recent study has shown that adult females have markedly more RFRP-1-ir per cell being regulated in the estrous cycle compared with male rats (27). Additionally, GnIH-3 was a secreted neurohormone that could be released into the portal blood to reduce the effects of GnRH through modulating pituitary gonadotropes during the anestrous and luteal follicular periods of the estrous cycle in the reproduction phases in ewes (24). In the dorso/ventromedial hypothalamus of jerboa captured in the spring, the RFRP transcription level was observed to increase compared to autumn (14).

RFRP-3 is proven to repress the reproductive axis via NPFF1R (75) so that lack of its inhibitory pathway partially hindered suppression of gonadotropin in the NPFF1 receptors of null mice in puberty and fertility under metabolic stress (30). GJ14 is a highly potent and specific NPFF1R antagonist with moderate antagonism at NPFF2R. It was observed that RFRP-3 was a promoter of hypothalamus-pituitary-adrenal (HPA) axis in mice, while infusion of GJ14 reversed the anxiogenic and HPA axis-stimulatory impacts of RFRP-3 (42). Interestingly, the findings presented suggest that not only in female animals, but also in male Syrian hamsters, the expression of RFRP was impacted markedly by reproduction condition and photoperiod, which suggests that RFRP in testis partly leads to reproductive inhibition (76). Female sexual behavior and motivation coordinate with the optimal time of fertility (77). RFRP acts as an activator of female proceptive sexual behavior and motivation, and this role is independent of the downstream alterations in the production of sex steroids such as circulating gonadal steroids and kisspeptin (45). As reflected by a multitude of expounded experiments (78-81), RFRP is more likely to play a temporary role in reproductive suppression in response to different physiological stimuli during the breeding season.

Role of RFRP in pregnancy

Pregnancy is a complex period of reproduction during which females carry one or more live offspring from implantation in the uterus through gestation and from egg fertilization to parturition. Plasma progesterone, which is synthesized by the nervous system from cholesterol de novo (82, 83), is a prominent indicator measured by radioimmunoassay through pregnancy and lactation in females (82). It has been clearly shown that treatment with progesterone or treatment with estradiol plus progesterone significantly decreased activation of RFRP-3 cells in the Syrian hamster DMH, whereas treatment with estradiol alone increased activation of RFRP-3 cells in the hamster DMH (84). Partly owing to their neuroanatomical connectivity, GnIH neurons have been proposed to be regulated by progesterone in seasonally breeding birds (85). Furthermore, it has been shown that GnIH adaptively reacts to unpredictable changes in the environment in a potentially conserved way in female periods in starlings and rats, especially in the period of parental care (39). The responsive patterns in RFRP-3 mRNA may derive from joint exposure to suppression of LH levels and increased levels of progesterone in pregnant rats (86). These results provide an anatomical and physiological basis for RFRPs acting as effectors of reproduction function of mammals.

Given that it has been determined that serum LH tends to decrease to the lowest level at mid-pregnancy and recover at the end of pregnancy, it is not surprising that RFRP is associated with secretion of GnRH and LH (87). An emerging discovery is that the levels of GnRH and LH secretion were decreased in the hypothalamus of pregnant rats, promoting the hypothesis that GnRH and LH secretion may be controlled by transcription conditions of RFRP-3 and LH genes (87). Similar to RFRP-3, kisspeptin is also a neuropeptide belonging to the large RFamide peptide subfamily. A recent research has discovered that in mice kisspeptin and RFRP-3 act as strong modulators to stimulate and inhibit GnRH and LH secretion, respectively (43). The expression of hypothalamic Kiss1 and Kiss1r mRNAs was characterized in pregnant and non-pregnant mice, the circadian input to Kiss1 in pregnancy is absent despite normal clock gene expression and high degrees of gestational estradiol (88). Therefore, a plausible explanation consistent with these data is that perturbations of kisspeptin-specific diurnal rhythm may operate in the non-pregnant state. However, further recordings are still needed to report potential roles of RFRP in pregnancy of mammals.

Role of RFRP in milking

The effects of milking are associated with regulation of reproductive endocrine hormones regulating from lactation to negative energy balance effects on neuroendocrine pathways. In various mammalian species, ovulation and follicular maturation are hindered in lactation (89). It is well understood that the inhibition of the estrous cycle mostly results from the inhibition of GnRH and LH secretion (90). RFRP serves as the potential regulator of LH and GnRH secretion, and has been assumed in biological mechanisms in the process of lactation.

Early recordings of the increase of RFRP-3 transcription in DMH may inhibit GnRH release at the stage of milk production increase in rats, compared with no variation in Kiss1 mRNA expression found in the ARC of the same rats, suggesting the lower activity of ARC on expressing the gene postpartum (91). In particular, one study in the DMH of rats has demonstrated that RFRP mRNA expression is stimulated by the suckling intensity and increased litter size, which may have a strong effect on lactation anestrus (40). Conversely, RFRP-3 genes are shown to increase the levels of the reproductive hormones to induce an immune response but have a minor role in improving twinning rate and litter sizes of ewes (19). A more careful examination of constructing DNA vaccines with the fragment of inhibin-α (INH) using the RFRP-3 gene in mice revealed that p-TPA-SINH/TPA-SFRFP inserted with INH and RFRP genes is successfully constructed with good immunogenicity, providing the possibility to increase litter size, effectively (19).

Role of RFRP in menopause

Menopause, the point when females end showing the estrous cycle, is connected with endocrine regulation in pituitary, hypothalamus, and gonads. It is now well understood that aging is correlated with HPG axis disruption in the downstream and decreased GnRH release. Although GnRH is the most famous hormone for pulsatile secretion to interact with the pituitary gland, which in turn interacts with the ovaries through LH and FSH release from puberty onset (92), the RFamide peptide superfamily, including 26/43 RFa, kisspeptins, GnIH and RFRPs, has recently attracted considerable attention owing to its role in reproductive aging that may be a factor for regulating menopause (5).

A recent rat-based study has proven that the expression of RFRP-3 and its receptor locally increase in the ovarian life-span with age (92). In the same study, the transcriptional increase of RFRP-3 is exhibited in the hypothalamus at middle age earlier than changes in estrous cyclicity (38). Furthermore, this increase is proven to be transient and followed by decreases in both the mRNA expression of GnRH and kisspeptin. Likewise, RFRP-3 inhibits the levels of LH secretion in postmenopausal women; however, compared with men administrated with GnIH/RFRP-3, the secretion of LH stimulated by kisspeptin is not decreased (23).

HPG and the HPT axes are integrated networks that can modulate both androgenization and estrogenization involving embryonic infancy, puberty and adult sexual maturation. Abnormalities in the HPT axis may induce some functional changes of male aging, resulting in sarcopenia, adiposity, osteopenia, insulin resistance, and impaired recovery from prolonged critical illness (93, 94). Further researches should resolve whether the same rules apply to female aging, which is largely correlated with dysregulation of the HPG axis, leading to the climacteric syndrome.

Role of RFRP in ovarian diseases

Abnormalities of reproductive hormones and reproductive dysregulation are characterized by symptoms of LH hypersecretion, hyperandrogenism that leads to hirsutism, follicular maturation dysregulation resulting in ovulatory disturbance, and subfertility (95, 96). A recent study provided cues that GnIH is involved in pubertal disorder induced by abnormalities in the thyroid. The interaction between HPT and HPG axes was reported to mediate via GnIH in abnormal puberty in mice (66), providing molecular targets for the treatment of pubertal disorder resulting from thyroid dysfunction (97).

Role of RFRP in infertility

High psychological anxiety and stress lead to long-lasting impaired fertility, including delayed pregnancy success, and reduced libido to complete reproductive axis suppression particularly in hypothalamic amenorrhea (98). The stress-induced RFRP-3 increase induces long-term suppression of reproductive periods (99). Along this line, there is some evidence that RFRPs could respond differently to any particular stressor, regardless of whether it is chronic or acute (100).

Role of RFRP in polycystic ovary syndrome

Polycystic ovary syndrome (PCOS) is a series of symptoms resulting from the increased androgens in women after puberty (101). Many useful clinical manifestations of PCOS are connected with reproductive, endocrine, psychological, and metabolic disorders. Hyperandrogenism and ovulatory dysfunction due to polycystic ovaries are the most prominent features of PCOS (96). Dysregulation of RFRP-3 secretion in the PCOS has been shown (63, 102). A rodent model of PCOS through neonatal chronic testosterone administration is used, causing vaginal opening onset to occur earlier in puberty. Interestingly, the mRNA expression of hypothalamic RFRP in testosterone-treated rats is decreased; however, this change stayed unchanged in their serum LH levels. The discovery indicates that sexual maturation in PCOS rats can be created through a peripheral mechanism instead of a central one (63).

The effects of reproductive function and sexual maturation are heavily implicated in the neonatal and/or prepubertal androgen milieu (103). The levels of serum LH and hypothalamic Kiss1 mRNA expression are decreased and their uterine weight increased in chronic dehydroepiandrosterone (DHEA)-treated rats, suggesting that RFRP-3 might directly affect the regulation of DHEA and/or estrogen in reproductive phenotypes (104). Furthermore, RFRP-3 agonists or LH-secretion related inhibitors may pharmacologically contribute to improving the treatments of steroid-dependent diseases, including endometriosis, benign prostatic hyperplasia, and precocious puberty (29, 105). To specifically address the reciprocal relationship in menstrual cyclicity and levels of plasma kisspeptin, plasma kisspeptin levels of eight female volunteers have been measured (106). Compared with males, the plasma kisspeptin levels are evidently higher in males. However, no significant relationship is found between sex hormones and plasma kisspeptin levels. As suggested by these data, their work reveals that kisspeptin may act as a driver of the beginning of menstruation and advance of menstruation covered for weakened functions of the ovary. Expanding on this research, recordings based on ovarian diseases reveal correlation with RFRP and its receptor.

RF313, a new orally active neuropeptide FF (NPFF) receptor antagonist, is considered to hinder hyperalgesia development induced by fentanyl in rats. An emerging theme is that RF313 has been proven to serve as a pharmacological tool to research the roles of NPFF1R and RFRPs in regulating reproduction (107). These results provide plausible evidence that RFRP-3 may have the potential for treating hormone-dependent diseases, reproductive diseases and hypothalamus-related ailments, including benign prostatic hyperplasia, uterine fibroids, endometriosis, breast cancers, and precocious puberty; exploring the methods by which the ovarian and reproductive diseases or syndromes in the RFRP system and its modulatory mechanisms represent a current novel wave. Recent studies using pharmacological manipulations unraveled that gonadal RFRP reacts to cues from influences gonadal steroids release and peripheral hormones (108-110). Therefore, there is a crucial need to recognize that involvement of RFRP in female fertility and the RFRP system in reproductive tissues is a potential target for contraceptive or reproductive therapies.

Conclusions and future outlooks

Reproduction is regulated via a complex network of stimulatory factors of peripheral and central origins that integrate at the HPG axis. We have witnessed tremendous advances in identifying crucial neuropeptides, RFRPs, involved in coding and processing the mammalian reproductive process. In this review article, the impacts of RFRP on biochemistry and molecular physiology, different periods during mammalian ovarian development in a variety of species, its present application, and therapeutic potential in ovarian diseases were discussed. Further studies are required for exploring whether modulation of RFRP-1 is confined to endocrines without coding the reproductive process, or whether reciprocal or overlapping projections existing between RFRP-3 and RFRP-1 regularize the ovarian lifespan of mammals, or whether RPRP plays an essential role in prenatal and early post-natal ovarian development, or how the neural and gonadal GnIH systems respond to hormones and stressors in different species. Moreover, the physiological mechanisms of the RFRP system in treating mammalian ovarian diseases and reproductive diseases is a brand new exciting frontier awaiting further investigation.

Conflicts of Interest

The authors declare that there are no conflicts of interest.

Acknowledgment

This work was financially supported by The Persian Gulf Biomedical Sciences Research Institute, Bushehr University of Medical Sciences, Bushehr, Iran.

References

  • 1.Tsutsui K, Saigoh E, Ukena K, Teranishi H, Fujisawa Y, Kikuchi M, et al. A novel avian hypothalamic peptide inhibiting gonadotropin release. Biochem Biophys Res Commun. 2000;275:661–667. doi: 10.1006/bbrc.2000.3350. [DOI] [PubMed] [Google Scholar]
  • 2.Umatani C, Abe H, Oka Y. Neuropeptide RFRP inhibits the pacemaker activity of terminal nerve GnRH neurons. J Neurophysiol. 2013;109:2354–2363. doi: 10.1152/jn.00712.2012. [DOI] [PubMed] [Google Scholar]
  • 3.Ullah R, Batool A, Wazir M, Naz R, Rahman TU, Wahab F, et al. Gonadotropin inhibitory hormone and RF9 stimulate hypothalamic-pituitary-adrenal axis in adult male rhesus monkeys. Neuropeptides. 2017;66:1–7. doi: 10.1016/j.npep.2017.07.005. [DOI] [PubMed] [Google Scholar]
  • 4.Jennings KJ, Chang J, Cho H, Piekarski DJ, Russo KA, Kriegsfeld LJ. Aggressive interactions are associated with reductions in RFamide-related peptide, but not kisspeptin, neuronal activation in mice. Horm Behav. 2016;78:127–134. doi: 10.1016/j.yhbeh.2015.10.021. [DOI] [PubMed] [Google Scholar]
  • 5.Henningsen JB, Poirel VJ, Mikkelsen JD, Tsutsui K, Simonneaux V, Gauer F. Sex differences in the photoperiodic regulation of RF-Amide related peptide (RFRP) and its receptor GPR147 in the syrian hamster. J Comp Neurol. 2016;524:1825–1838. doi: 10.1002/cne.23924. [DOI] [PubMed] [Google Scholar]
  • 6.Saenz de Miera C, Monecke S, Bartzen-Sprauer J, Laran-Chich MP, Pevet P, Hazlerigg DG, et al. A circannual clock drives expression of genes central for seasonal reproduction. Curr Biol. 2014;24:1500–1506. doi: 10.1016/j.cub.2014.05.024. [DOI] [PubMed] [Google Scholar]
  • 7.Kovacs A, Laszlo K, Galosi R, Toth K, Ollmann T, Peczely L, et al. Microinjection of RFRP-1 in the central nucleus of amygdala decreases food intake in the rat. Brain Res Bull. 2012;88:589–595. doi: 10.1016/j.brainresbull.2012.06.001. [DOI] [PubMed] [Google Scholar]
  • 8.Ullah R, Shen Y, Zhou YD, Huang K, Fu JF, Wahab F, et al. Expression and actions of GnIH and its orthologs in vertebrates: Current status and advanced knowledge. Neuropeptides. 2016;59:9–20. doi: 10.1016/j.npep.2016.05.004. [DOI] [PubMed] [Google Scholar]
  • 9.Decourt C, Anger K, Robert V, Lomet D, Bartzen-Sprauer J, Caraty A, et al. No evidence that RFamide-related peptide 3 directly modulates LH secretion in the ewe. Endocrinology. 2016;157:1566–1575. doi: 10.1210/en.2015-1854. [DOI] [PubMed] [Google Scholar]
  • 10.Henningsen JB, Ancel C, Mikkelsen JD, Gauer Fo, Simonneaux Vr. Roles of RFRP-3 in the daily and seasonal regulation of reproductive activity in female Syrian hamsters. Endocrinology. 2017;158:652–663. doi: 10.1210/en.2016-1689. [DOI] [PubMed] [Google Scholar]
  • 11.Han X, He Y, Zeng G, Wang Y, Sun W, Liu J, et al. Intracerebroventricular injection of RFRP-3 delays puberty onset and stimulates growth hormone secretion in female rats. Reprod Biol Endocrinol. 2017;15:35. doi: 10.1186/s12958-017-0254-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Peragine DE, Pokarowski M, Mendoza-Viveros L, Swift-Gallant A, Cheng HM, Bentley GE, et al. RFamide-related peptide-3 (RFRP-3) suppresses sexual maturation in a eusocial mammal. Proc Natl Acad Sci U S A. 2017;114:1207–1212. doi: 10.1073/pnas.1616913114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Ancel C, Inglis MA, Anderson GM. Central RFRP-3 stimulates LH secretion in male mice and has cycle stage-dependent inhibitory effects in females. Endocrinology . 2017:2016–1902. doi: 10.1210/en.2016-1902. [DOI] [PubMed] [Google Scholar]
  • 14.Talbi R, Klosen P, Laran-Chich MP, El Ouezzani S, Simonneaux V. Coordinated seasonal regulation of metabolic and reproductive hypothalamic peptides in the desert jerboa. J Comp Neurol. 2016;524:3717–3728. doi: 10.1002/cne.24026. [DOI] [PubMed] [Google Scholar]
  • 15.Simonneaux Vr, Ancel C. RFRP neurons are critical gatekeepers for the photoperiodic control of reproduction. Front Endocrinol. 2012;3:225–233. doi: 10.3389/fendo.2012.00168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Zhao L, Zhong M, Xue H-L, Ding J-S, Wang S, Xu J-H, et al. Effect of RFRP-3 on reproduction is sex-and developmental status-dependent in the striped hamster (Cricetulus barabensis) Gene. 2014;547:273–279. doi: 10.1016/j.gene.2014.06.054. [DOI] [PubMed] [Google Scholar]
  • 17.Thorson JF, Heidorn NL, Ryu V, Czaja K, Nonneman DJ, Barb CR, et al. Relationship of neuropeptide FF receptors with pubertal maturation of gilts. Biol Reprod. 2017;96:617–634. doi: 10.1095/biolreprod.116.144998. [DOI] [PubMed] [Google Scholar]
  • 18.Zheng L, Su J, Fang R, Jin M, Lei Z, Hou Y, et al. Developmental changes in the role of gonadotropin-inhibitory hormone (GnIH) and its receptors in the reproductive axis of male Xiaomeishan pigs. Anim Reprod Sci. 2015;154:113–120. doi: 10.1016/j.anireprosci.2015.01.004. [DOI] [PubMed] [Google Scholar]
  • 19.Dan X, Liu X, Han Y, Liu Q, Yang L. Effect of the novel DNA vaccine fusing inhibin α (1-32) and the RF-amide related peptide-3 genes on immune response, hormone levels and fertility in Tan sheep. Anim Reprod Sci. 2016;164:105–110. doi: 10.1016/j.anireprosci.2015.11.018. [DOI] [PubMed] [Google Scholar]
  • 20.Huang DW, Di R, Wang JX, Chu MX, He JN, Cao GL, et al. Analysis on DNA sequence of goat RFRP gene and its possible association with average daily sunshine duration. Mol Biol Rep. 2012;39:9167–9177. doi: 10.1007/s11033-012-1789-3. [DOI] [PubMed] [Google Scholar]
  • 21.Tanco VM, Whitlock BK, Jones MA, Wilborn RR, Brandebourg TD, Foradori CD. Distribution and regulation of gonadotropin-releasing hormone, kisspeptin, RF-amide related peptide-3, and dynorphin in the bovine hypothalamus. Peer J. 2016;4:e1833. doi: 10.7717/peerj.1833. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Wahab F, Drummer C, Schlatt S, Behr Rd. Dynamic regulation of hypothalamic DMXL2, KISS1, and RFRP expression during postnatal development in non-human primates. Mol Neurobiol. 2017;54:8447–8457. doi: 10.1007/s12035-016-0329-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.George JT, Hendrikse M, Veldhuis JD, Clarke IJ, Anderson RA, Millar RP. Effect of gonadotropin-inhibitory hormone on luteinizing hormone secretion in humans. Clin Endocrinol (Oxf) 2017;86:731–738. doi: 10.1111/cen.13308. [DOI] [PubMed] [Google Scholar]
  • 24.Smith JT, Young IR, Veldhuis JD, Clarke IJ. Gonadotropin-inhibitory hormone (GnIH) secretion into the ovine hypophyseal portal system. Endocrinology. 2012;153:3368–3375. doi: 10.1210/en.2012-1088. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Russo KA, La JL, Stephens SBZ, Poling MC, Padgaonkar NA, Jennings KJ, et al. Circadian control of the female reproductive axis through gated responsiveness of the RFRP-3 system to VIP signaling. Endocrinology. 2015;156:2608–2618. doi: 10.1210/en.2014-1762. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Salehi MS, Tamadon A, Shirazi MRJ, Namavar MR, Zamiri MJ. The role of arginine-phenylalanine-amide-related peptides in mammalian reproduction. Int J Fertil Steril. 2015;9:268–276. doi: 10.22074/ijfs.2015.4540. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Jørgensen SR, Andersen MD, Overgaard A, Mikkelsen JD. Changes in RFamide-related peptide-1 (RFRP-1)-immunoreactivity during postnatal development and the estrous cycle. Endocrinology. 2014;155:4402–4410. doi: 10.1210/en.2014-1274. [DOI] [PubMed] [Google Scholar]
  • 28.Xiang W, Zhang B, Lv F, Ma Y, Chen H, Chen L, et al. The inhibitory effects of RFamide-related peptide 3 on luteinizing hormone release involves an estradiol-dependent manner in prepubertal but not in adult female mice. Biol Reprod. 2015;93 doi: 10.1095/biolreprod.115.128777. [DOI] [PubMed] [Google Scholar]
  • 29.Lima CJG, Cardoso SC, Lemos EFL, Zingler E, Capanema C, Menezes LD, et al. Mutational analysis of the genes encoding RFamide-related peptide-3, the human orthologue of gonadotrophin-inhibitory hormone, and its receptor (GPR147) in patients with gonadotrophin-releasing hormone-dependent pubertal disorders. J Neuroendocrinol. 2014;26:817–824. doi: 10.1111/jne.12207. [DOI] [PubMed] [Google Scholar]
  • 30.León S, García-Galiano D, Ruiz-Pino F, Barroso A, Manfredi-Lozano M, Romero-Ruiz A, et al. Physiological roles of gonadotropin-inhibitory hormone signaling in the control of mammalian reproductive axis: studies in the NPFF1 receptor null mouse. Endocrinology. 2014;155:2953–2965. doi: 10.1210/en.2014-1030. [DOI] [PubMed] [Google Scholar]
  • 31.Smith P, Wilhelm D, Rodgers RJ. Development of mammalian ovary. J Endocrinol. 2014;221:R145–161. doi: 10.1530/JOE-14-0062. [DOI] [PubMed] [Google Scholar]
  • 32.Iwasa T, Matsuzaki T, Yano K, Irahara M. Gonadotropin-inhibitory hormone plays roles in stress-induced reproductive dysfunction. Front Endocrinol. 2017;8:62. doi: 10.3389/fendo.2017.00062. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Fang MX, Huang YS, Ye J, Zhang W, Li Y, Nie QH. Identification and characterization of RFRP gene in pigs and its association with reproductive traits. Genet Mol Res. 2014;13:1661–1671. doi: 10.4238/2014.January.14.8. [DOI] [PubMed] [Google Scholar]
  • 34.Li X, Su J, Fang R, Zheng L, Lei R, Wang X, et al. The effects of RFRP-3, the mammalian ortholog of GnIH, on the female pig reproductive axis in vitro. Mol Cell Endocrinol. 2013;372:65–72. doi: 10.1016/j.mce.2013.03.015. [DOI] [PubMed] [Google Scholar]
  • 35.Thorson JF, Desaulniers AT, Lee C, White BR, Ford JJ, Lents CA. The role of RFamide-related peptide 3 (RFRP3) in regulation of the neuroendocrine reproductive and growth axes of the boar. Anim Reprod Sci. 2015;159:60–65. doi: 10.1016/j.anireprosci.2015.05.013. [DOI] [PubMed] [Google Scholar]
  • 36.Jafarzadeh Shirazi MR, Pazoohi F, Zamiri MJ, Salehi MS, Namavar MR, Tamadon A, et al. Expression of RFamide-related peptide in the dorsomedial nucleus of hypothalamus during the estrous cycle of rats. Physiol Pharmacol. 2013;17:72–79. [Google Scholar]
  • 37.Salehi MS, Shirazi MRJ, Zamiri MJ, Pazhoohi F, Namavar MR, Niazi A, et al. Hypothalamic expression of KiSS1 and RFamide-related peptide-3 mRNAs during the estrous cycle of rats. Int J Fertil Steril. 2013;6:304–309. [PMC free article] [PubMed] [Google Scholar]
  • 38.Geraghty AC, Muroy SE, Kriegsfeld LJ, Bentley GE, Kaufer D. The role of RFamide-related peptide-3 in age-related reproductive decline in female rats. Front Endocrinol. 2016;7:71. doi: 10.3389/fendo.2016.00071. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Calisi RM, Geraghty AC, Avila A, Kaufer D, Bentley GE, Wingfield JC. Patterns of hypothalamic GnIH change over the reproductive period in starlings and rats. Gen Comp Endocrinol. 2016;237:140–146. doi: 10.1016/j.ygcen.2016.08.015. [DOI] [PubMed] [Google Scholar]
  • 40.Noroozi A, Shirazi MRJ, Tamadon A, Moghadam A, Niazi A. Increased litter size and suckling intensity stimulate mRNA of RFamide-related peptide in rats. Int J Fertil Steril. 2015;9:380–386. doi: 10.22074/ijfs.2015.4554. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Poling MC, Kim J, Dhamija S, Kauffman AS. Development, sex steroid regulation, and phenotypic characterization of RFamide-related peptide (Rfrp) gene expression and RFamide receptors in the mouse hypothalamus. Endocrinology. 2012;153:1827–1840. doi: 10.1210/en.2011-2049. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Kim JS, Brownjohn PW, Dyer BS, Beltramo M, Walker CS, Hay DL, et al. Anxiogenic and stressor effects of the hypothalamic neuropeptide RFRP-3 are overcome by the NPFFR antagonist GJ14. Endocrinology. 2015;156:4152–4162. doi: 10.1210/en.2015-1532. [DOI] [PubMed] [Google Scholar]
  • 43.Poling MC, Quennell JH, Anderson GM, Kauffman AS. Kisspeptin neurones do not directly signal to RFRP-3 neurones but RFRP-3 may directly modulate a subset of hypothalamic kisspeptin cells in mice. J Neuroendocrinol. 2013;25:876–886. doi: 10.1111/jne.12084. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Ancel C, Bentsen AH, Sébert M-E, Tena-Sempere M, Mikkelsen JD, Simonneaux Vr. Stimulatory effect of RFRP-3 on the gonadotrophic axis in the male Syrian hamster: the exception proves the rule. Endocrinology. 2012;153:1352–1363. doi: 10.1210/en.2011-1622. [DOI] [PubMed] [Google Scholar]
  • 45.Piekarski DJ, Zhao S, Jennings KJ, Iwasa T, Legan SJ, Mikkelsen JD, et al. Gonadotropin-inhibitory hormone reduces sexual motivation but not lordosis behavior in female Syrian hamsters (Mesocricetus auratus) Horm Behav. 2013;64:501–510. doi: 10.1016/j.yhbeh.2013.06.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Bentley GE, Wilsterman K, Ernst DK, Lynn SE, Dickens MJ, Calisi RM, et al. Neural Versus Gonadal GnIH: Are they Independent Systems? A Mini-Review. Integr Comp Biol. 2017;57:1194–1203. doi: 10.1093/icb/icx085. [DOI] [PubMed] [Google Scholar]
  • 47.Clarke IJ, Sari IP, Qi Y, Smith JT, Parkington HC, Ubuka T, et al. Potent action of RFamide-related peptide-3 on pituitary gonadotropes indicative of a hypophysiotropic role in the negative regulation of gonadotropin secretion. Endocrinology. 2008;149:5811–5821. doi: 10.1210/en.2008-0575. [DOI] [PubMed] [Google Scholar]
  • 48.Murakami M, Matsuzaki T, Iwasa T, Yasui T, Irahara M, Osugi T, et al. Hypophysiotropic role of RFamide-related peptide-3 in the inhibition of LH secretion in female rats. J Endocrinol. 2008;199:105–112. doi: 10.1677/JOE-08-0197. [DOI] [PubMed] [Google Scholar]
  • 49.Johnson MA, Tsutsui K, Fraley GS. Rat RFamide-related peptide-3 stimulates GH secretion, inhibits LH secretion, and has variable effects on sex behavior in the adult male rat. Horm Behav. 2007;51:171–180. doi: 10.1016/j.yhbeh.2006.09.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Kriegsfeld LJ, Mei DF, Bentley GE, Ubuka T, Mason AO, Inoue K, et al. Identification and characterization of a gonadotropin-inhibitory system in the brains of mammals. Proc Natl Acad Sci U S A. 2006;103:2410–2415. doi: 10.1073/pnas.0511003103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Tsutsui K, Ubuka T. GnIH Control of Feeding and Reproductive Behaviors. Front Endocrinol (Lausanne) 2016;7:170. doi: 10.3389/fendo.2016.00170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Gibson EM, Humber SA, Jain S, Williams WP, 3rd , Zhao S, Bentley GE, et al. Alterations in RFamide-related peptide expression are coordinated with the preovulatory luteinizing hormone surge. Endocrinology. 2008;149:4958–4969. doi: 10.1210/en.2008-0316. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Ducret E, Anderson GM, Herbison AE. RFamide-related peptide-3, a mammalian gonadotropin-inhibitory hormone ortholog, regulates gonadotropin-releasing hormone neuron firing in the mouse. Endocrinology. 2009;150:2799–2804. doi: 10.1210/en.2008-1623. [DOI] [PubMed] [Google Scholar]
  • 54.Gojska NM, Belsham DD. Glucocorticoid receptor-mediated regulation of Rfrp (GnIH) and Gpr147 (GnIH-R) synthesis in immortalized hypothalamic neurons. Mol Cell Endocrinol. 2014;384:23–31. doi: 10.1016/j.mce.2013.12.015. [DOI] [PubMed] [Google Scholar]
  • 55.Ubuka T, Ukena K, Sharp PJ, Bentley GE, Tsutsui K. Gonadotropin-inhibitory hormone inhibits gonadal development and maintenance by decreasing gonadotropin synthesis and release in male quail. Endocrinology. 2006;147:1187–1194. doi: 10.1210/en.2005-1178. [DOI] [PubMed] [Google Scholar]
  • 56.Bentley GE, Ubuka T, McGuire NL, Chowdhury VS, Morita Y, Yano T, et al. Gonadotropin-inhibitory hormone and its receptor in the avian reproductive system. Gen Comp Endocrinol. 2008;156:34–43. doi: 10.1016/j.ygcen.2007.10.003. [DOI] [PubMed] [Google Scholar]
  • 57.Sethi S, Chaturvedi CM. Physiological evidence of an inverse correlation between the gonadal function and rfrp-3 neurons in mice. Int J Bioassays. 2015;4:4022–4024. [Google Scholar]
  • 58.Soga T, Dalpatadu SL, Wong DW, Parhar IS. Neonatal dexamethasone exposure down-regulates GnRH expression through the GnIH pathway in female mice. Neuroscience. 2012;218:56–64. doi: 10.1016/j.neuroscience.2012.05.023. [DOI] [PubMed] [Google Scholar]
  • 59.Losa-Ward SM, Todd KL, McCaffrey KA, Tsutsui K, Patisaul HB. Disrupted organization of RFamide pathways in the hypothalamus is associated with advanced puberty in female rats neonatally exposed to bisphenol A. Biol Reprod. 2012;87:28. doi: 10.1095/biolreprod.112.100826. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Howdeshell KL, Hotchkiss AK, Thayer KA, Vandenbergh JG, vom Saal FS. Exposure to bisphenol A advances puberty. Nature. 1999;401:763–764. doi: 10.1038/44517. [DOI] [PubMed] [Google Scholar]
  • 61.Adewale HB, Jefferson WN, Newbold RR, Patisaul HB. Neonatal bisphenol-a exposure alters rat reproductive development and ovarian morphology without impairing activation of gonadotropin-releasing hormone neurons. Biol Reprod. 2009;81:690–699. doi: 10.1095/biolreprod.109.078261. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Iwasa T, Matsuzaki T, Murakami M, Kinouchi R, Osugi T, Gereltsetseg G, et al. Developmental changes in the mammalian gonadotropin-inhibitory hormone (GnIH) ortholog RFamide-related peptide (RFRP) and its cognate receptor GPR147 in the rat hypothalamus. Int J Dev Neurosci. 2012;30:31–37. doi: 10.1016/j.ijdevneu.2011.10.003. [DOI] [PubMed] [Google Scholar]
  • 63.Iwasa T, Matsuzaki T, Tungalagsuvd A, Munkhzaya M, Kuwahara A, Yasui T, et al. The advancement of the onset of vaginal opening in female rats subjected to chronic testosterone treatment occurs independently of hypothalamic Kiss1 and RFRP expression. Neuroendocrinol Lett. 2015;36:767–770. [PubMed] [Google Scholar]
  • 64.Li H, Song H, Huang M, Nie H, Wang Z, Wang F. Impact of food restriction on ovarian development, RFamide-related peptide-3 and the hypothalamic-pituitary-ovarian axis in pre-pubertal ewes. Reprod Domest Anim. 2014;49:831–838. doi: 10.1111/rda.12375. [DOI] [PubMed] [Google Scholar]
  • 65.Poling MC, Kauffman AS. Regulation and function of RFRP-3 (GnIH) neurons during postnatal development. Front Endocrinol. 2015;6:150. doi: 10.3389/fendo.2015.00150. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Kiyohara M, Son YL, Tsutsui K. Involvement of gonadotropin-inhibitory hormone in pubertal disorders induced by thyroid status. Sci Rep. 2017;7:1042. doi: 10.1038/s41598-017-01183-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Li X, Su J, Lei Z, Zhao Y, Jin M, Fang R, et al. Gonadotropin-inhibitory hormone (GnIH) and its receptor in the female pig: cDNA cloning, expression in tissues and expression pattern in the reproductive axis during the estrous cycle. Peptides. 2012;36:176–185. doi: 10.1016/j.peptides.2012.05.008. [DOI] [PubMed] [Google Scholar]
  • 68.Williams WP, 3rd , Kriegsfeld LJ. Circadian control of neuroendocrine circuits regulating female reproductive function. Front Endocrinol (Lausanne) 2012;3:60. doi: 10.3389/fendo.2012.00060. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Legan SJ, Karsch FJ. A daily signal for the LH surge in the rat. Endocrinology. 1975;96:57–62. doi: 10.1210/endo-96-1-57. [DOI] [PubMed] [Google Scholar]
  • 70.Kriegsfeld LJ, Korets R, Silver R. Expression of the circadian clock gene Period 1 in neuroendocrine cells: an investigation using mice with a Per1:: GFP transgene. Eur J Neurosci. 2003;17:212–220. doi: 10.1046/j.1460-9568.2003.02431.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Khan AR, Kauffman AS. The role of kisspeptin and RFamide-related peptide-3 neurones in the circadian-timed preovulatory luteinising hormone surge. J Neuroendocrinol. 2012;24:131–143. doi: 10.1111/j.1365-2826.2011.02162.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Kadokawa H, Shibata M, Tanaka Y, Kojima T, Matsumoto K, Oshima K, et al. Bovine C-terminal octapeptide of RFamide-related peptide-3 suppresses luteinizing hormone (LH) secretion from the pituitary as well as pulsatile LH secretion in bovines. Domest Anim Endocrinol. 2009;36:219–224. doi: 10.1016/j.domaniend.2009.02.001. [DOI] [PubMed] [Google Scholar]
  • 73.Sethi S, Tsutsui K, Chaturvedi CM. Temporal phase relation of circadian neural oscillations alters RFamide-related peptide-3 and testicular function in the mouse. Neuroendocrinology. 2010;91:189–199. doi: 10.1159/000265760. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Sethi S, Chaturvedi CM. Temporal synergism of neurotransmitters and role of RFamide-related peptide-3. Biomed Res. 2016;1:16–35. [Google Scholar]
  • 75.Clarke IJ, Qi Y, Puspita Sari I, Smith JT. Evidence that RF-amide related peptides are inhibitors of reproduction in mammals. Front Neuroendocrinol. 2009;30:371–378. doi: 10.1016/j.yfrne.2009.04.001. [DOI] [PubMed] [Google Scholar]
  • 76.Zhao S, Zhu E, Yang C, Bentley GE, Tsutsui K, Kriegsfeld LJ. RFamide-related peptide and messenger ribonucleic acid expression in mammalian testis: association with the spermatogenic cycle. Endocrinology. 2010;151:617–627. doi: 10.1210/en.2009-0978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Nequin LG, Alvarez J, ScHwartz NB. Steroid control of gonadotropin release. J Steroid Biochem. 1975;6:1007–1012. doi: 10.1016/0022-4731(75)90342-8. [DOI] [PubMed] [Google Scholar]
  • 78.Bentley GE, Perfito N, Ukena K, Tsutsui K, Wingfield JC. Gonadotropin-inhibitory peptide in song sparrows (Melospiza melodia) in different reproductive conditions, and in house sparrows (Passer domesticus) relative to chicken-gonadotropin-releasing hormone. J Neuroendocrinol. 2003;15:794–802. doi: 10.1046/j.1365-2826.2003.01062.x. [DOI] [PubMed] [Google Scholar]
  • 79.Calisi RM, Diaz-Munoz SL, Wingfield JC, Bentley GE. Social and breeding status are associated with the expression of GnIH. Genes Brain Behav. 2011;10:557–564. doi: 10.1111/j.1601-183X.2011.00693.x. [DOI] [PubMed] [Google Scholar]
  • 80.McGuire NL, Koh A, Bentley GE. The direct response of the gonads to cues of stress in a temperate songbird species is season-dependent. PeerJ. 2013;1:e139. doi: 10.7717/peerj.139. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Calisi RM, Rizzo NO, Bentley GE. Seasonal differences in hypothalamic EGR-1 and GnIH expression following capture-handling stress in house sparrows (Passer domesticus) Gen Comp Endocrinol. 2008;157:283–287. doi: 10.1016/j.ygcen.2008.05.010. [DOI] [PubMed] [Google Scholar]
  • 82.Buchanan GD, Younglai EV. Plasma progesterone levels during pregnancy in the little brown bat Myotis lucifugus (Vespertilionidae) Biol Reprod. 1986;34:878–884. doi: 10.1095/biolreprod34.5.878. [DOI] [PubMed] [Google Scholar]
  • 83.Yarim G, Karahan S. Regional brain and sex differences in the plasma progesterone concentration of sheep. Small Ruminant Res. 2007;71:98–102. [Google Scholar]
  • 84.Benton NA, Russo KA, Brozek JM, Andrews R, Kim V, Kriegsfeld LJ, et al. Food restriction-induced changes in motivation differ with stages of the estrous cycle and are closely linked to RFamide-related peptide-3 but not kisspeptin in Syrian hamsters. Physiol Behav. 2018;190:43–60. doi: 10.1016/j.physbeh.2017.06.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.Ubuka T, Bentley GE, Tsutsui K. Neuroendocrine regulation of gonadotropin secretion in seasonally breeding birds. Front Neurosci. 2013;7 doi: 10.3389/fnins.2013.00038. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86.Bentley G, Ubuka T, McGuire N, Calisi R, Perfito N, Kriegsfeld L, et al. Gonadotrophin-inhibitory hormone: a multifunctional neuropeptide. J Neuroendocrinol. 2009;21:276–281. doi: 10.1111/j.1365-2826.2009.01851.x. [DOI] [PubMed] [Google Scholar]
  • 87.Sarvestani FS, Tamadon A, Koohi-Hosseinabadi O, Nezhad SM, Rahmanifar F, Shirazi MRJ, et al. Expression of RFamide-related peptide-3 (RFRP-3) mRNA in dorsomedial hypothalamic nucleus and KiSS-1 mRNA in arcuate nucleus of rat during pregnancy. Int J Fertil Steril. 2014;8:333–340. [PMC free article] [PubMed] [Google Scholar]
  • 88.Yap CC, Wharfe MD, Mark PJ, Waddell BJ, Smith JT. Diurnal regulation of hypothalamic kisspeptin is disrupted during mouse pregnancy. J Endocrinol. 2016;229:307–318. doi: 10.1530/JOE-16-0086. [DOI] [PubMed] [Google Scholar]
  • 89.Butler WR. Nutritional interactions with reproductive performance in dairy cattle. Anim Reprod Sci. 2000;60-61:449–457. doi: 10.1016/s0378-4320(00)00076-2. [DOI] [PubMed] [Google Scholar]
  • 90.Fox SR, Smith MS. The suppression of pulsatile luteinizing hormone secretion during lactation in the rat. Endocrinology. 1984;115:2045–2051. doi: 10.1210/endo-115-6-2045. [DOI] [PubMed] [Google Scholar]
  • 91.Asadi Yousefabad SL, Tamadon A, Rahmanifar F, Jafarzadeh Shirazi MR, Sabet Sarvestani F, Tanideh N, et al. Lactation effect on the mRNAs expression of RFRP-3 and KiSS-1 in dorsomedial and arcuate nuclei of the rat hypothalamus. Physiol Pharmacol. 2013;17:277–285. [Google Scholar]
  • 92.Hernández-Angeles C, Castelo-Branco C. Early menopause: A hazard to a woman’s health. Indian J Med Res. 2016;143 doi: 10.4103/0971-5916.184283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 93.Liu PY. Assessing new peptides that may be involved in the physiological regulation of the gonadal axis in humans: gonadotrophin inhibitory hormone. Clin Endocrinol (Oxf) 2017;86:658–659. doi: 10.1111/cen.13328. [DOI] [PubMed] [Google Scholar]
  • 94.Kim YJ, Tamadon A, Park HT, Kim H, Ku S-Y. The role of sex steroid hormones in the pathophysiology and treatment of sarcopenia. Osteoporos Sarcopenia. 2016;2:140–155. doi: 10.1016/j.afos.2016.06.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 95.Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol. 2011;7:219–231. doi: 10.1038/nrendo.2010.217. [DOI] [PubMed] [Google Scholar]
  • 96.Rahmanifar F, Nooranizadeh MH, Tamadon A, Rajabi-Aslani J, Koohi-Hosseinabadi O, Shirazi MRJ, et al. Histomorphometric comparison of induction of polycystic ovary syndrome by exposure to constant light in primiparous and nulliparous rats. Iran J Sci Technol A Sci. 2018;42:421–430. [Google Scholar]
  • 97.Tsutsui K, Son YL, Kiyohara M, Miyata I. Mini-review: Discovery of GnIH and its role in hypothyroidism-induced delayed puberty. Endocrinology. 2018;159:62–68. doi: 10.1210/en.2017-00300. [DOI] [PubMed] [Google Scholar]
  • 98.Louis GMB, Lum KJ, Sundaram R, Chen Z, Kim S, Lynch CD, et al. Stress reduces conception probabilities across the fertile window: evidence in support of relaxation. Fertil Steril. 2011;95:2184–2189. doi: 10.1016/j.fertnstert.2010.06.078. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 99.Geraghty AC, Muroy SE, Zhao S, Bentley GE, Kriegsfeld LJ, Kaufer D. Knockdown of hypothalamic RFRP3 prevents chronic stress-induced infertility and embryo resorption. Elife. 2015;4:e04316. doi: 10.7554/eLife.04316. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 100.Rudolph LM, Bentley GE, Calandra RS, Paredes AH, Tesone M, Wu TJ, et al. Peripheral and central mechanisms involved in the hormonal control of male and female reproduction. J Neuroendocrinol. 2016;28:1–12. doi: 10.1111/jne.12405. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 101.Fauser BC, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R, et al. Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril. 2012;97:28–38. doi: 10.1016/j.fertnstert.2011.09.024. [DOI] [PubMed] [Google Scholar]
  • 102.Shaaban Z, Shirazi MRJ, Nooranizadeh MH, Tamadon A, Rahmanifar F, Ahmadloo S, et al. Decreased expression of arginine-phenylalanine-amide-related peptide-3 gene in dorsomedial hypothalamic nucleus of constant light exposure model of polycystic ovarian syndrome. Int J Fertil Steril. 2018;12:43–50. doi: 10.22074/ijfs.2018.5206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 103.Walters KA, Allan CM, Handelsman DJ. Rodent models for human polycystic ovary syndrome. Biol Reprod. 2012;149:141–112. doi: 10.1095/biolreprod.111.097808. [DOI] [PubMed] [Google Scholar]
  • 104.Iwasa T, Matsuzaki T, Tungalagsuvd A, Munkhzaya M, Yiliyasi M, Kato T, et al. Effects of chronic DHEA treatment on central and peripheral reproductive parameters, the onset of vaginal opening and the estrous cycle in female rats. Gynecol Endocrinol. 2016;32:752–755. doi: 10.3109/09513590.2016.1163672. [DOI] [PubMed] [Google Scholar]
  • 105.He Y, Sun W, Yu J. Is precocious puberty linked to hypothalamic expression of arginine-phenylalanine-amide-related peptide? Iran J Basic Med Sci. 2017;20:1074–1078. doi: 10.22038/IJBMS.2017.9397. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 106.Katagiri F, Kotani M, Hirai T, Kagawa J. The relationship between circulating kisspeptin and sexual hormones levels in healthy females. Biochem Biophys Res Commun. 2015;458:663–666. doi: 10.1016/j.bbrc.2015.02.021. [DOI] [PubMed] [Google Scholar]
  • 107.Elhabazi K, Humbert JP, Bertin I, Quillet R, Utard Vr, Schneider Sv, et al. RF313, an orally bioavailable neuropeptide FF receptor antagonist, opposes effects of RF-amide-related peptide-3 and opioid-induced hyperalgesia in rodents. Neuropharmacology. 2017;118:188–198. doi: 10.1016/j.neuropharm.2017.03.012. [DOI] [PubMed] [Google Scholar]
  • 108.McGuire NL, Bentley GE. Neuropeptides in the Gonads: From Evolution to Pharmacology. Front Pharmacol. 2010;1:114. doi: 10.3389/fphar.2010.00114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 109.Bentley GE, Kriegsfeld LJ, Osugi T, Ukena K, O’Brien S, Perfito N, et al. Interactions of gonadotropin-releasing hormone (GnRH) and gonadotropin-inhibitory hormone (GnIH) in birds and mammals. J Exp Zool A Comp Exp Biol. 2006;305:807–814. doi: 10.1002/jez.a.306. [DOI] [PubMed] [Google Scholar]
  • 110.Bentley GE, Ubuka T, McGuire NL, Calisi R, Perfito N, Kriegsfeld LJ, et al. Gonadotrophin-inhibitory hormone: a multifunctional neuropeptide. J Neuroendocrinol. 2009;21:276–281. doi: 10.1111/j.1365-2826.2009.01851.x. [DOI] [PubMed] [Google Scholar]

Articles from Iranian Journal of Basic Medical Sciences are provided here courtesy of Mashhad University of Medical Sciences

RESOURCES